A strain producing indigo and its construction method and application
By constructing the indigo synthesis pathway gene in Saltmonas and optimizing the tryptophan branch pathway, combined with low-cost carbon source fermentation, the existing indigo biosynthesis process is solved, and high-efficiency and low-cost indigo is achieved Production.
Patent Information
- Application Number
- CN202410047688.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Priority Date
- 2024-01-08
- Filing Date
- 2024-01-11
- Publication Date
- 2024-11-26
- Estimated Expiration
- 2044-01-11
AI Technical Summary
The existing indigo biosynthesis process is complex and has high cost and low yield. The traditional methods rely on expensive catalysts and environmental pollution problems, so we need to seek efficient synthesis methods that are green and energy-saving.
By constructing the indigo synthetic pathway genes tnaA and fmo are expressed in Saltmonas, and using CRISPR/Cas9 to knock out the branch pathway gene, optimize the promoter and overexpress tryptophan-related genes, improve NADPH regeneration, and use low-cost carbon source glucose Sodium fermentation is carried out.
It has achieved a significant increase in indigo production, reduced production costs, avoided the use of expensive catalysts, and was simple in process and suitable for industrial production.
Smart Images

Figure CN118421669B_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the field of biotechnology, and in particular to an indigo-producing strain and a construction method and application thereof. Background Art
[0002] Indigo, also known as blue indigo and indigo blue, is an ancient traditional pigment widely used in food, medicine, printing and dyeing, and cosmetics industries. At present, natural indigo is mainly extracted from plants such as indigofera tinctoria, woad, indigofera tinctoria, and wild indigo plant. It has bright and durable colors and high safety. However, with the increasing demand for blue pigments, the complex and limited process has restricted the development of plant extraction and has gradually been replaced by chemical synthesis. However, the chemical method consumes expensive catalysts and causes environmental pollution, which is not in line with the current national development strategy. Therefore, it is urgent to achieve efficient synthesis of indigo in a green and energy-saving way.
[0003] At present, the biosynthesis of indigo is mainly achieved by adding precursor compounds such as aminophenylethanol as substrates, and using alcohol dehydrogenase and flavin monooxygenase to catalyze the reaction to produce indigo. However, the traditional process of producing indigo is complicated, resulting in excessively high fermentation costs and low indigo yields. The biosynthesis of whole cells is limited to model strains such as Escherichia coli and Pseudomonas, and the yield of indigo is also not high. Therefore, there is an urgent need for a method that can reduce production costs, simplify the production process, and increase indigo yields to meet the needs of continuous production. Summary of the invention
[0004] In view of the defects in the prior art, the present invention proposes a strain for producing indigo and a construction method and application thereof.
[0005] The present invention provides a method for constructing an indigo-producing strain, comprising the following steps:
[0006] S1: amplify the target gene sequences of tnaA and fmo in vitro, insert them into the vector, and obtain the first vector plasmid;
[0007] S2: Introducing the first vector plasmid of S1 into Halomonas;
[0008] S3: The endogenous pheA and pykF gene sequences were knocked out in the Halomonas described in S2, and the trpD-trpC-trpB-trpA target gene fragment was inserted into the genome of the Halomonas described in S2.
[0009] Wherein, the nucleotide sequence of tnaA is shown in SEQ ID No.47; the nucleotide sequence of fmo is shown in SEQ ID No.48;
[0010] The nucleotide sequence of trpD-trpC-trpB-trpA is shown in SEQ ID No.42; the nucleotide sequence of pheA is shown in SEQ ID No.49; and the nucleotide sequence of pykF is shown in SEQ ID No.50.
[0011] Furthermore, the Halomonas in step S2 is any one of Halomonas sp.LY01, Halomonas sp.TD01, Halomonas sp.LY02, Halomonas sp.LY03, and Halomonas campaniensis LY04.
[0012] The Halomonas sp.LY01 strain used in the present invention has been deposited in Guangdong Microbiological Culture Collection Center (GDMCC for short, address: 5th Floor, Building 59, No. 100, Xianlie Middle Road, Guangzhou, Guangdong Institute of Microbiology, zip code 510070) on July 19, 2022. The deposit number is GDMCC No: 62635. The strain name is Halomonas sp.LY01, and the classification name is Halomonas sp.
[0013] The Halomonas sp.LY02 strain used in this application has been deposited in the Guangdong Provincial Microbiological Culture Collection Center (GDMCC for short, address: 5th Floor, Building 59, No. 100, Xianlie Middle Road, Guangzhou, Guangdong Institute of Microbiology, Postal Code 510070) on April 23, 2023. The deposit number is GDMCC No: 63381. The strain name is Halomonas sp.LY02, and the classification name is Halomonas sp.
[0014] The Halomonas sp.LY03 strain used in this application has been deposited in the Guangdong Provincial Microbiological Culture Collection Center (GDMCC for short, address: 5th Floor, Building 59, No. 100, Xianlie Middle Road, Guangzhou, Guangdong Institute of Microbiology, Postal Code 510070) on April 23, 2023. The deposit number is GDMCC No: 63382. The strain name is Halomonas sp.LY03, and the classification name is Halomonas sp.
[0015] The Halomonas sp.LY04 strain used in this application has been deposited in Guangdong Provincial Microbiological Culture Collection Center (GDMCC for short, address: 5th Floor, Building 59, No. 100, Xianlie Middle Road, Guangzhou, Guangdong Institute of Microbiology, Postal Code 510070) on April 23, 2023. The deposit number is GDMCC No: 63383. The strain name is Halomonas sp.LY04, and the classification name is Halomonas sp.
[0016] Furthermore, the first vector plasmid in step S1 contains a promoter, and the promoter is Porin 58 .
[0017] Furthermore, in step S2, a second vector plasmid is also introduced into the salt mononas, and the second vector plasmid contains any one target gene sequence of gnd, pntA-pntB, nadk, and ppnk; the gnd, pntA-pntB, nadk, and ppnk gene sequences are obtained by in vitro amplification.
[0018] Among them, the nucleotide sequence of gnd is shown in SEQ ID No.43; the nucleotide sequence of pntA-pntB is shown in SEQ ID No.44; the nucleotide sequence of nadk is shown in SEQ ID No.45; and the nucleotide sequence of ppnk is shown in SEQ ID No.46.
[0019] The present invention also provides an indigo-producing strain obtained by the construction method.
[0020] The present invention also provides a method for producing indigo using the strain, comprising the following steps:
[0021] (1) Preparation of seed solution;
[0022] Furthermore, the fermentation medium used in the fermentation in step (2) contains a carbon source, and the carbon source is one or more of glucose and sodium gluconate; sodium gluconate has low cost and can increase the yield of indigo.
[0023] Furthermore, the fermentation temperature in step (2) is 30-45°C, preferably 36-38°C.
[0024] Furthermore, the pH of the fermentation in step (2) is 7-10.
[0025] Furthermore, the fermentation time in step (2) is 10 to 100 hours, preferably 36 to 48 hours.
[0026] In summary, compared with the prior art, the present invention achieves the following technical effects:
[0027] 1. The present invention utilizes Halomonas to produce indigo, and the yield of indigo is high. In a shake flask with a fermentation liquid volume of 20 mL, the yield can reach up to 3.15 g / L.
[0028] 2. The method for producing indigo of the present invention is simple and does not require the addition of expensive catalysts, thereby improving the effect of industrial production of indigo and reducing production costs. BRIEF DESCRIPTION OF THE DRAWINGS
[0029] In order to more clearly illustrate the technical solutions of the embodiments of the present invention, the drawings required for use in the embodiments are briefly introduced below. It should be understood that the following drawings only show certain embodiments of the present invention and therefore should not be regarded as limiting the scope. For ordinary technicians in this field, other related drawings can be obtained based on these drawings without creative work.
[0030] Figure 1 is a pathway diagram of the indigo production pathway of the present invention;
[0031] Figure 2 pSEVA321 of Example 1 of the present invention lacI_tnaA-fmo Vector plasmid map;
[0032] Figure 3 This is the electrophoresis diagram of the tnaA-fmo target fragment in Example 1 of the present invention;
[0033] Figure 4 This is a standard curve diagram for determining the indigo content in the embodiment of the present invention;
[0034] Figure 5 pSEVA321 of Example 3 of the present invention Plux_tanA-PMmp1_fmo Vector plasmid map;
[0035] Figure 6 This is the electrophoresis diagram of the tnaA-fmo target fragment in Example 3 of the present invention;
[0036] Figure 7 pSEVA321 of Example 3 of the present invention Porin58_tanA-Porin58_fmo Vector plasmid map;
[0037] Figure 8 This is the electrophoresis diagram of the target fragment verified in Example 3 of the present invention;
[0038] Fig. 9 This is the electrophoresis diagram of the target fragment verified in Example 4 of the present invention;
[0039] Fig.10 pSEVA321 of Example 5 of the present invention Porin226_trpD-trpC-trpB-trpA Vector plasmid map;
[0040] Fig.11 pSEVA321 of Example 5 of the present invention Porin140_trpD-trpC-trpB-trpA Vector plasmid map;
[0041] Fig.12 This is the electrophoresis diagram of the trpD-trpC-trpB-trpA target fragment in Example 5 of the present invention;
[0042] Fig.13 This is the electrophoresis diagram of the trpD-trpC-trpB-trpA target fragment in Example 5 of the present invention;
[0043] Fig.14 pSEVA341 of Example 6 of the present invention gnd Vector plasmid map;
[0044] Fig.15 pSEVA341 of Example 6 of the present invention pntA-pntB Vector plasmid map;
[0045] Fig.16 pSEVA341 of Example 6 of the present invention nadk Vector plasmid map;
[0046] Fig.17 pSEVA341 of Example 6 of the present invention ppnk Vector plasmid map;
[0047] Fig.18 This is the electrophoresis diagram of the gnd target fragment in Example 6 of the present invention;
[0048] Fig.19 This is the electrophoresis diagram of the pntA-pntB target fragment in Example 6 of the present invention;
[0049] Fig. 20 This is the electrophoresis diagram of the target fragment of nddk in Example 6 of the present invention;
[0050] Fig.21 This is the electrophoresis diagram of the pnnk target fragment in Example 6 of the present invention. DETAILED DESCRIPTION
[0051] In order to enable those skilled in the art to better understand the scheme of the present invention, the technical scheme in the embodiments of the present invention will be clearly and completely described below in conjunction with the drawings in the embodiments of the present invention. Obviously, the described embodiments are only embodiments of a part of the present invention, not all embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without making creative work should fall within the scope of protection of the present invention.
[0052] Halomonas itself cannot synthesize indigo. The first part of the present invention constructs a biosynthetic pathway for indigo including tnaA, fmo (such as Figure 1 As shown in Figure 2, the tnaA and fmo genes were constructed under the control of inducible promoters, and the inducer was optimized to increase the yield of indigo. In view of the high price of inducers and the possible instability of the induction system, the dual inducible promoter system was replaced with a constitutive promoter Porin with corresponding strength. 58 At the same time, the recombinant strain carrying this plasmid was compared with the strain carrying the double-inducible promoter plasmid to verify whether the promoters matched. It was found that the constitutive promoter Porin 58 Indigo production was improved compared to the dual inducible promoter.
[0053] In the second part of the present invention, through genome comparison analysis, the presence of branch enzymes PheA (prephenate dehydratase) and PykF (pyruvate kinase) that may affect tryptophan flux is found in the Halomonas sp.LY01 genome. The present invention uses CRISPR / Cas9 gene editing technology to knock out the branch pathway-related genes pheA and pykF in the metabolic network, thereby increasing the carbon flow to the synthetic indigo pathway, and further increasing the indigo yield based on the first part.
[0054] The third part of the present invention verifies whether the indigo yield can be further increased by increasing the accumulation of tryptophan by overexpressing genes related to chorismate to tryptophan, including anthranilate synthase (encoded by trpE gene), anthranilate pyrophosphotransferase encoded by trpD gene), anthranilate isomerase encoded by trpC gene), tryptophan synthase encoded by trpB gene), and indoleglycerol 3-phosphatase encoded by trpA gene;
[0055] Considering that the synthesis pathway of indigo involves the use of NADPH, one molecule of NADPH is consumed for each molecule of indigo. The fourth part of the present invention uses a strategy that can improve NADPH regeneration to verify whether the carbon metabolism flow can be maximized to indigo to increase indigo production. In order to increase the supply of NADPH, NADPH-related genes are overexpressed, mainly including:
[0056] (1) Pentose phosphorylation pathway (PP pathway): overexpression of 6-phosphodiesterase from Escherichia coli K12 MG1655, encoded by the gnd gene;
[0057] (2) Increase NADPH / NADP +Ratio: Overexpression of NAD kinase from E. coli K12 MG1655 and C. glutamicum ATCC 13032, encoded by nadk and ppnk genes, and pyridine nucleotide transhydrogenase from E. coli K12 MG1655, encoded by pntA-pntB genes, achieves a balance of cofactors and further increases the indigo content.
[0058] The experimental methods used in the following examples are all conventional methods unless otherwise specified. The materials and reagents used can be obtained from commercial sources unless otherwise specified. Halomonas sp. TD01 was obtained from Tsinghua University.
[0059] Example 1 Construction of indigo synthesis pathway
[0060] 1. Construction of expression plasmid containing tnaA and fmo genes
[0061] The Ptac inducible promoter was used to control the tnaA gene from E. coli K12 MG1655 and the fmo gene from Methylophaga aminisulfidivorans. The gene fragment and the plasmid backbone fragment were PCR amplified using Q5 high-fidelity DNA polymerase and connected using Gibson Assembly Master Mix (purchased from NewEngland Biolabs) to obtain the target connection product pSEVA321 Ptac_tnaA-fmo , tnaA-fmo sequence information is shown in SEQ ID No.39, pSEVA321 Ptac_tnaA-fmo Plasmid information such as Figure 2 shown.
[0062] The primer sequences (5'-3') for PCR amplification of tnaA, fmo target gene fragments and pSEVA321 plasmid backbone are as follows:
[0063] pSEVA321-Ptac-F: see SEQ ID No.1; pSEVA321-Ptac-R: see SEQ ID No.2;
[0064] tnaA-F: see SEQ ID No.3; tnaA-R: see SEQ ID No.4;
[0065] fmo-F: see SEQ ID No.5; fmo-R: see SEQ ID No.6.
[0066] The vector and gene sequence were used as templates, respectively. The total reaction volume was 50 μL. The components shown in Table 1 were added in sequence in a 0.2 mL PCR tube;
[0067] Table 1 PCR components of Q5 high-fidelity DNA polymerase
[0068] Components Reaction system Forward Primer (10 μmol / L) 2.5μL Reverse Primer (10 μmol / L) 2.5μL Q5 High-Fidelity 2×Master Mix 25μL Template DNA(<200ng) 1μL <![CDATA[dd H2O]]> To 50μL
[0069] After mixing, centrifuge immediately. The reaction parameters are: pre-denaturation at 98°C for 30s; denaturation at 98°C for 10s, annealing at 50-72°C for 30s, extension at 72°C for 30s / kb, and final extension at 72°C for 2min after 32 cycles of extension. The above vector and gene were recovered using a universal DNA purification kit (Tiangen Biochemical Technology Co., Ltd.), and the operation was performed according to the steps provided in the product manual.
[0070] The vector and gene obtained in (1) above were recombined into a new plasmid. The connection was performed using Gibson Assembly Master Mix (purchased from New England Biolabs). The total reaction volume was 10 μL. The components in Table 2 were added in sequence to a 0.2 mL PCR tube, where the backbone, fragment tnaA, and fragment fmo were added in amounts of 3 μL, 1 μL, and 1 μL, respectively.
[0071] Table 2 Components and addition amounts of Gibson Assembly Master Mix enzyme ligation
[0072]
[0073]
[0074] Mix well on ice and heat at 50°C for 60 minutes to obtain the ligation product. After ligation, transform the sample into E. coli S17-1 competent cells, shake and culture at 37°C and 220rpm for 1 hour, draw an appropriate volume and evenly spread it on the LB agar medium plate containing chloramphenicol antibiotics, and then invert and culture overnight. After verifying the positive single colony by bacterial liquid PCR, send it to Sangon Biotech (Shanghai) Co., Ltd. for sequencing.
[0075] 2. Introduction of recombinant plasmid into Halomonas sp.LY01
[0076] The transformed E. coli S17-1 and Halomonas sp.LY01 were cultured separately and the OD 600When it reaches 0.6-0.8, take 50 μL of each, mix in a 1:1 ratio and spread on a 20LB plate without antibiotics, and let it bind for 6-8 hours; then pick a small amount of the combined bacteria and place them on a 60LB plate containing antibiotic Cm, and perform PCR colony verification after 36-48 hours.
[0077] The results showed that the tnaA-fmo gene sequence was successfully transferred into the Halomonas sp.LY01 strain. The size of the target fragment product was verified by PCR. Figure 3 As shown, the target fragment is 2954 bp, which is consistent with the expected result. The strain introduced with the indigo synthesis pathway was named LY01-a.
[0078] Example 2 Synthesis of indigo using modified bacteria
[0079] The LY01-a strain of Example 1 was used for fermentation culture.
[0080] 1. Seed solution preparation
[0081] (1) Bacterial Activation
[0082] The LY01-a strain was activated on a 60LB plate containing Cm at 37°C for 24 h until a single colony grew;
[0083] (2) Primary seed solution: The single clone selected in step (1) was inoculated into a shaking tube containing 5 mL of seed medium (60 LB) and 5 μL Cm, and cultured at 37°C, 220 rpm for 12 h;
[0084] (3) Secondary seed solution: Take the bacterial solution in step (2) and inoculate 1% into a 150 mL conical flask containing 20 mL seed culture medium (60LB) and 20 μL Cm, and culture at 37°C, 220 rpm for 12 h.
[0085] 2. Indigo shake flask fermentation production (20mL)
[0086] (1) Culture medium preparation: 50MM culture medium system:
[0087] Base material: NaCl 50g / L, yeast powder 1g / L; Component I: MgSO4 20g / L, urea 25g / L; Component II: KH2PO4 175g / L; Component III: 5g / L Fe(III)-NH4-Citrate, 2g / L CaCl2·2H2O and (12mol / L) concentrated hydrochloric acid 41.7mL are fully mixed and the volume is fixed to 1L; Component IV: ZnSO4·7H2O 0.1g / L, MnCl2·4H2O 0.03g / L, H3BO3 0.3g / L, CoCl2·6H2O 0.2g / L, CuSO4·5H2O 0.01g / L, NiCl2·6H2O 0.02g / L and NaMoO4·2H2O0.03g / L; Components III & IV: Take 100mL of component III and 10mL of component IV, add 90mL of deionized water to mix, and finally adjust the pH value to 4.5-5.5 with 5M NaOH.
[0088] Carbon source: glucose 30g / L, sodium gluconate 36g / L, glucose 15g / L + sodium gluconate 18g / L;
[0089] L-Tryptophan 1g / L.
[0090] The fermentation production adopted a 50MM culture system. The seed liquid was inoculated at 5% into a 150mL conical flask containing 20mL of culture medium, and 0, 2, 10, 20, 100, and 200mg / L of inducer IPTG were added respectively. The culture was placed in a shaker at 37°C and 220rpm for 48h.
[0091] (2) Detect OD after fermentation 600 , cell dry weight and indigo content
[0092] OD 600 : Take 1 mL of the fermented bacterial solution, centrifuge at 12000 rpm for 10 min, discard the supernatant, add an equal volume of deionized water, resuspend the bacteria, and use a spectrophotometer to detect the absorbance at a wavelength of 600 nm (if necessary, dilute the bacterial solution to ensure that the reading of the spectrophotometer at a wavelength of 600 nm is within the range of 0.3 to 0.8).
[0093] Cell dry weight (CDW): Place 10-15 mL of fermented bacterial liquid in a 50 mL centrifuge tube, centrifuge at 8000 rpm at room temperature for 6 min, and remove the supernatant (minimize the loss of solid precipitate); add deionized water to restore the original volume, resuspend, ensure that the precipitate disappears completely, centrifuge at 8000 rpm at room temperature for 6 min, and remove the supernatant; seal the centrifuge tube with sealing film and freeze it in a refrigerator at 80°C for 0.5-2 h; dry the centrifuge tube in a vacuum freeze dryer for 12-16 hours; weigh and calculate the cell dry weight.
[0094] Indigo content detection: 1 mL of fermented bacterial liquid was placed in a 1.5 mL EP tube, centrifuged at 12000 rpm at room temperature for 10 min, and the supernatant was removed (to minimize the loss of solid precipitate); then deionized water was added to restore the original volume and resuspended to ensure that the precipitate completely disappeared, centrifuged at 12000 rpm at room temperature for 10 min, and the supernatant was removed; then an equal volume of dimethyl sulfoxide (DMSO) was added to resuspend the bacteria to dissolve indigo in DMSO, centrifuged at 12000 rpm at room temperature for 10 min, 0.2 mL of supernatant was added to the ELISA plate, and the plate was placed on an ELISA instrument to detect the absorbance at 610 nm, and the indigo content was calculated according to the standard curve equation. The standard curve is as follows: Figure 4 shown.
[0095] (3) Fermentation results
[0096] Different carbon sources were tested, and the indigo yields were compared when glucose 30 g / L, glucose 15 g / L + sodium gluconate 18 g / L, and sodium gluconate 36 g / L were used as carbon sources. The results are shown in Table 3; the indigo yields at different IPTG concentrations are shown in Table 4.
[0097] Table 3 Results of shake flask fermentation of indigo synthesis with 1 g / L precursor tryptophan added under different carbon sources
[0098] Glucose: Sodium gluconate (g / L) Indigo content (mg / L) CDW(g / L) 30:0 110.5 14.56 15:18 164.7 13.32 0:36 195.8 12.49
[0099] Table 4 Results of shake flask fermentation of indigo synthesis with 1 g / L precursor tryptophan added at different IPTG concentrations
[0100] IPTG(mg / L) Indigo content (mg / L) CDW(g / L) 0 0.2 14.92 2 20.1 11.76 10 100.9 12.17 20 120.4 11.36 100 214.2 9.00 200 239.5 9.11
[0101] From the above results, it can be seen that when 36g / L sodium gluconate is used as the sole carbon source, the indigo yield is higher than that when glucose is used as the carbon source and the combination of glucose and sodium gluconate is used as the carbon source, reaching 19.8mg / L; when the IPTG addition amount is 200mg / L, the cell dry weight (CDW) is 11.36g / L and the indigo content is as high as 239.5mg / L.
[0102] Example 3 Promoter Optimization of Transformed Strains
[0103] 1. Construction of plasmids for dual inducible promoter system
[0104] This example improves indigo production by optimizing the expression levels of the two genes tnaA and fmo. lux IPTG-induced P Mmp1 ) respectively control the expression of tnaA and fmo genes. For the specific plasmid construction method, see Example 1 to construct plasmid pSEVA321Plux_tanA-PMmp1_fmo , plasmid map such as Figure 5 As shown. lux _tanA-P Mmp1 The _fmo gene sequence is shown in SEQ ID No.42.
[0105] Using PCR to amplify P lux _tanA-P Mmp1 The primers for _fmo are as follows (5'-3'):
[0106] Vector pSEVA321 Plux_tanA-PMmp1_fmo -F: see SEQ ID No.7;
[0107] Vector pSEVA321 Plux_tanA-PMmp1_fmo -R: see SEQ ID No.8;
[0108] tnaA-F2: see SEQ ID No.9; tnaA-R2: see SEQ ID No.10;
[0109] P lux -F: see SEQ ID No.11; P lux -R: see SEQ ID No.12;
[0110] fmo-F2: see SEQ ID No.13; fmo-R2: see SEQ ID No.14.
[0111] According to the method of Example 1, plasmid pSEVA321 Plux_tanA-PMmp1_fmo The target fragment was transferred into the Halomonas sp. LY01 strain, and the size of the target fragment product was verified by PCR. Figure 6 As shown, the target fragment is 2954 bp, which is consistent with the expected result. The strain introduced with the double inducible promoter plasmid was named LY01-b.
[0112] 2. Optimization of inducer for recombinant strains carrying dual inducible promoter plasmids
[0113] The LY01-b strain constructed in this example was cultured by shake flask fermentation to measure the accumulation of indigo synthesized from scratch using the double induction plasmid. Except that L-tryptophan was not added to the culture medium, the carbon source was 36 g / L sodium gluconate, and different inducer addition amounts (IPTG concentration was 2, 10, 20 mg / L; OC6 concentration was 0.01, 0.1, 1 mg / L), the remaining components were the same as in Example 2, and the indigo and CDW detection methods were the same as in Example 2. The results are shown in Table 5.
[0114] Table 5 Indigo production (mg / L) at different IPTG concentrations without adding 1 g / L precursor tryptophan
[0115]
[0116] From the results in Table 5, it can be seen that when the addition amount of inducer OC6 is 0.1 mg / L and the addition amount of IPTG is 10 mg / L, the indigo yield is the highest, which can reach 321.56 mg / L.
[0117] 3. Constitutive promoter controls indigo synthesis gene expression
[0118] In view of the high price of inducers and the possible instability of the induction system, in this example, the dual inducible promoter system was replaced with a constitutive promoter of corresponding strength, and the promoter corresponding to the tnaA gene was replaced with Porin 58 The constitutive promoter and fmo gene corresponding promoter were replaced with Porin 58 The constitutive promoter was used to construct a constitutive plasmid named pSEVA321 Porin58_tanA-Porin58_fmo , plasmid map such as Figure 7 As shown;
[0119] PCR amplification of tanA, fmo and pSEVA321 Porin58 The primers are as follows (5'-3'):
[0120] tnaA-F3: see SEQ ID No.15; tnaA-R3: see SEQ ID No.16;
[0121] fmo-F3: see SEQ ID No.17; fmo-R3: see SEQ ID No.18;
[0122] pSEVA321 Porin58 -F: see SEQ ID No.19; pSEVA321 Porin58 -R: see SEQ ID No.20.
[0123] Porin 58 _tanA-Porin 58 The nucleotide sequence of _fmo is shown in SEQ ID No.41.
[0124] According to the method of Example 1, plasmid pSEVA321 Porin58_tanA-Porin58_fmo The target fragment was transferred into the Halomonas sp. LY01 strain, and the size of the target fragment product was verified by PCR. Figure 8As shown, the target fragment is 2954 bp, which is in line with the expected result. The strain into which the constitutive promoter plasmid was introduced was named LY01-c. The recombinant strain carrying this plasmid was compared with the strain carrying the double inducible promoter plasmid to verify whether the promoters matched. The culture and fermentation conditions were the same as in Example 2, and no inducer was added to the fermentation medium.
[0125] The indigo production yields of strains containing two different promoters are shown in Table 6.
[0126] Table 6 Indigo production by two modified bacteria (mg / L)
[0127] strain Indigo content (mg / L) CDW(g / L) LY01-b 320.5 12.40 LY01-c 350.67 12.17
[0128] From the results in Table 6, it can be seen that when the constitutive promoter is used to control the tnaA and fmo genes, the indigo yield is higher than that of the dual inducible promoter system, reaching 350.67 mg / L.
[0129] Example 4 Knockout of tryptophan branch pathway
[0130] 1. Knockout of pheA and pykF genes
[0131] CRISPR / Cas9 gene editing technology was used to knock out the pheA and pykF genes in the Halomonas sp.LY01 genome. The original expression vector used to express sgRNA and donor DNA was pSEVA341 plasmid (containing spectinomycin and kanamycin resistance genes). The sgRNA was inserted after the promoter J23119, and the homology arms (upstream and downstream homology arms abbreviated as H1 and H2) for knocking out the target genes pheA and pykF were connected after the sgRNA. The gRNA sequence involved in knocking out the pheA gene is shown in SEQ ID No. 21, and the gRNA sequence involved in knocking out the pykF gene is shown in SEQ ID No. 22.
[0132] The pSEVA341 plasmid expressing sgRNA and the pQ08 plasmid expressing Cas9 were transformed into Halomonas sp.LY01 by conjugation of E. coli S17 1 according to the method of Example 1. PCR was used to verify whether there were mutants that knocked out the target gene, such as Fig. 9 As shown, the target fragment was 2098 bp, which was consistent with the expected result, and the strain was subsequently sequenced. The strains introduced with the double inducible promoter plasmid were named LY01-ΔpheA, LY01-ΔpykF, and LY01-ΔpheAΔpykF.
[0133] 2. Expression of the tryptophan branch pathway
[0134] pSEVA321 from Example 4Porin58_tanA-Porin58_fmo The plasmids were conjugated into LY01-ΔpheA, LY01-ΔpykF and LY01-ΔpheAΔpykF strains according to the method of Example 1 to obtain LY01-ΔpheA+c, LY01-ΔpykF+c and LY01-ΔpheAΔpykF+c strains, respectively.
[0135] 3. Production of indigo using expression strains of the tryptophan branch pathway
[0136] The four strains of Examples 3 to 4 were used to perform fermentation culture to synthesize indigo. The specific culture conditions were as shown in Example 2. The fermentation results are shown in Table 7.
[0137] Table 7 Indigo production by different modified bacteria (mg / L)
[0138] strain Indigo yield (mg / L) CDW(g / L) LY01-c 533.52 12.78 LY01-ΔpheA+c 640.89 11.97 LY01-ΔpykF+c 748.68 12.43 LY01-ΔpheAΔpykF+c 955.23 11.68
[0139] From the above results, it can be seen that compared with LY01-c, LY01-ΔpheA+c and LY01-ΔpykF+c, the indigo production of LY01-ΔpheAΔpykF+c is as high as 955.23 mg / L. Therefore, LY01-ΔpheAΔpykF+c was subsequently used to strengthen the tryptophan branch synthesis pathway.
[0140] Example 5 Strengthening of the tryptophan branch synthesis pathway
[0141] 1. Using Porin 140 Porin 226 Two promoters of different strengths control the gene cluster trpD-trpC-trpB-trpA from E. coli K12MG1655. This gene cluster was integrated into LY01-ΔpheAΔpykF using CRISPR-Cas9 technology. The plasmid information is as follows: Figures 10-11 shown.
[0142] The primers for PCR amplification of trpD-trpC-trpB-trpA and cinR are as follows (5'-3'):
[0143] trpD-trpC-trpB-trpA-F: see SEQ ID No. 23;
[0144] trpD-trpC-trpB-trpA-R: see SEQ ID No. 24;
[0145] cinR-F: see SEQ ID No.25; cinR-R: see SEQ ID No.26.
[0146] This gene cluster was then integrated into the LY01-ΔpheAΔpykF+c strain using CRISPR-Cas9 technology, and the size of the target fragment product was verified by PCR, such as Fig.12 As shown in the figure, the target fragment is 4789 bp, which is in line with the expected result, and the Porin 140 Promoter strain LY01 ΔpheAΔpykF-Porin140_trpDCBA (LY01-d); Fig.13 As shown, the target fragment is 4789 bp, and the fragment containing Porin 226 Promoter strain LY01 ΔpheAΔpykF-Porin226_trpDCBA (LY01-e).
[0147] 2. Strain verification of tryptophan branch pathway enhancement
[0148] The LY01-ΔpheAΔpykF+c of Example 4 and the strain of this example were used for fermentation culture to synthesize indigo. The specific culture conditions were as shown in Example 2. The fermentation results are shown in Table 8.
[0149] Table 8 Indigo production by different modified bacteria (g / L)
[0150] strain Indigo production (g / L) CDW(g / L) LY01-ΔpheAΔpykF+c 0.956 11.58 LY01-d 1.38 11.32 LY01-e 1.74 11.02
[0151] From the above results, it can be seen that by overexpressing genes related to chorismate to tryptophan and selecting different promoters, the indigo production of LY01-e strain was further improved to as high as 1.74 g / L.
[0152] Example 6 Cofactor balance of modified bacteria
[0153] 1. Construction of NADPH regeneration related gene plasmid
[0154] Referring to the method of Example 1, the four genes gnd, pntA-pntB, nadk, and ppnk were constructed on the expression vector pSEVA341, and Porin 58 The promoter controls the expression of four genes, and the four plasmids are pSEVA341 gnd (like Fig.14 pSEVA341 pntA-pntB (like Fig.15 pSEVA341 nadk (like Fig.16 pSEVA341 ppnk (like Fig.17 The primers for PCR amplification of gnd, pntA-pntB, nadk, and ppnk are as follows (5'-3'):
[0155] pSEVA341-F1: see SEQ ID No.27; pSEVA341-R1: see SEQ ID No.28;
[0156] pSEVA341 ppnk -F: see SEQ ID No.29; pSEVA341 ppnk -R: see SEQ ID No.30;
[0157] gnd-F: see SEQ ID No.31; gnd-R: see SEQ ID No.32;
[0158] pntA-pntB-F: See SEQ ID No. 33; pntA-pntB-R: See SEQ ID No. 34;
[0159] nadk-F: see SEQ ID No.35; nadk-R: see SEQ ID No.36;
[0160] ppnk-F: see SEQ ID No.37; ppnk-R: see SEQ ID No.38.
[0161] 2. Construction of recombinant bacteria containing NADPH regeneration-related gene plasmids
[0162] Plasmid pSEVA341 gnd 、pSEVA341 pntA-pntB、 pSEVA341 nadk 、pSEVA341 ppnk The fragments were respectively joined to strain LY01-e according to the method of Example 1; the size of the target fragment product was verified by PCR, such as Fig.18 As shown, the gnd target fragment is 2076 bp, which is in line with the expected result and was introduced into pSEVA341 gnd The plasmid strain was named LY01-e-gnd; the pntA-pntB target fragment was 4032 bp, such as Fig.19 As shown, pSEVA341 was introduced pntA-pntB The plasmid strain was named LY01-e-pntA-pntB; the target fragment of nddk was 2106 bp, such as Fig. 20 As shown, pSEVA341 was introduced nadk The plasmid strain was named LY01-e-nadk; the pnnk target fragment was 1887 bp, such as Fig.21 As shown, pSEVA341 was introduced ppnk The strain carrying the plasmid was named LY01-e-ppnk.
[0163] Example 7 Production of indigo using five modified bacteria
[0164] Fermentation was performed using the LY01-e strain of Example 6 and the LY01-e-gnd, LY01-e-pntA-pntB, LY01-e-nadk, and LY01-e-ppnk strains of Example 7. The specific culture conditions are shown in Example 2, and the fermentation results are shown in Table 9.
[0165] Table 9 Indigo production by different modified bacteria (g / L)
[0166] strain Indigo production (g / L) CDW(g / L) LY01-e 1.92 11.12 LY01-e-gnd 1.93 10.37 LY01-e-pntA-pntB 2.68 10.09 LY01-e-nadk 2.35 10.95 LY01-e-ppnk 3.15 11.42
[0167] The results in Table 9 show that the ability of the four modified bacteria LY01-e-gnd, LY01-e-pntA-pntB, LY01-e-nadk, and LY01-e-ppnk to produce indigo was further improved, among which LY01-e-ppnk had the highest yield, reaching 3.15 g / L.
[0168] Example 8 Construction of recombinant Halomonas producing indigo
[0169] pSEVA321 constructed in Example 3 Porin58_tanA-Porin58_fmo The plasmids were respectively joined to Halomonas sp. TD01, Halomonas sp. LY02, Halomonas sp. LY03, and Halomonas sp. LY04 according to the method of Example 1, and the trpD-trpC-trpB-trpA gene cluster was inserted according to the method of Example 5, and the endogenous pheA and pykF gene sequences of the strains were knocked out.
[0170] Example 9 Production of indigo using recombinant Halomonas
[0171] The four strains constructed in Example 8 were used for fermentation according to the fermentation conditions and steps of Example 2. The results are shown in Table 10.
[0172] Table 10 Yield of indigo produced by different modified bacteria (g / L)
[0173] strain Indigo production (g / L) CDW(g / L) Halomonas sp.TD01 2.80 11.12 Halomonas sp.LY02 2.91 10.37 Halomonas sp.LY03 3.08 10.09 Halomonas sp.LY04 2.84 10.95
[0174] The results showed that all four strains of Halomonas were able to produce indigo with a high yield. This example illustrates that the method of the present application is not only applicable to a single strain of Halomonas, but also that high indigo production can be achieved by transferring tnaA and fmo genes into other Halomonas.
[0175] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. Any modifications, equivalent substitutions, improvements, etc. made within the spirit and principle of the present invention should be included in the protection scope of the present invention.
[0176] The nucleotide sequence of lacI_tnaA-fmo is shown in SEQ ID No.39, wherein 1373 to 2788 bp is the tnaA gene sequence, and 2815 to 4184 bp is the fmo gene sequence; lux _tanA-P Mmp1 The nucleotide sequence of _fmo is shown in SEQ ID No.40; Porin 58 _tanA-Porin 58 The nucleotide sequence of _fmo is shown in SEQ ID No.41; the nucleotide sequence of trpD-trpC-trpB-trpA is shown in SEQ ID No.42 (wherein 399-1995bp is the trpD gene sequence, 1996-3358bp is the trpC gene sequence, 3359-4564bp is the trpB gene sequence, and 4563-5370bp is the trpA gene sequence); the nucleotide sequence of gnd is shown in SEQ ID No.43; the nucleotide sequence of pntA-pntB is shown in SEQ ID No.44 (wherein 328-1861bp is the pntA gene sequence, and 1871-3260bp is the pntB gene sequence); the nucleotide sequence of nadk is shown in SEQ ID No.45; the nucleotide sequence of ppnk is shown in SEQ ID No.46; the nucleotide sequence of tnaA is shown in SEQ ID No.47; the nucleotide sequence of fmo is shown in SEQ ID No.48; the nucleotide sequence of pheA is shown in SEQ ID No.49; the nucleotide sequence of pyKF is shown in SEQ ID No.50.
Claims
1. A method for constructing an indigo-producing strain, characterized in that: The steps include: S1: In vitro amplification of tnaA and fmo target gene sequences, and Porin 58 _tanA-Porin 58 _fmo is inserted into the vector pSEVA321 to obtain the first vector plasmid; the Porin 58 _tanA-Porin 58 _fmo nucleotide sequence is shown in SEQ ID No.41; S2: Introducing the first vector plasmid of S1 into Halomonas; the Halomonas is any one of Halomonas sp.LY01, Halomonas sp.TD01, Halomonas sp.LY02, Halomonas sp.LY03, and Halomonas sp.LY04; the accession number of the Halomonas sp.LY01 is GDMCC No: 62635, the accession number of the Halomonas sp.LY02 is GDMCC No: 63381, the accession number of the Halomonas sp.LY03 is GDMCC No: 63382, and the accession number of the Halomonas sp.LY04 is GDMCC No: 63383; S3: knocking out the endogenous pheA and pykF gene sequences in the Halomonas described in S2, and inserting the trpD-trpC-trpB-trpA target gene fragment into the genome of the Halomonas described in S2; the nucleotide sequence of the pheA is shown in SEQ ID No.49; the nucleotide sequence of the pyKF is shown in SEQ ID No.50; wherein the gRNA sequence for knocking out the pheA gene is shown in SEQ ID No.21, and the gRNA sequence for knocking out the pykF gene is shown in SEQ ID No.22; the nucleotide sequence of the trpD-trpC-trpB-trpA is shown in SEQ ID No.42; In step S2, a second vector plasmid is also introduced into the Halomonas, wherein the second vector plasmid is obtained by inserting any one target gene sequence of pntA-pntB, nadk, and ppnk into the vector pSEVA321; The pntA-pntB, nadk, and ppnk gene sequences are obtained by in vitro amplification; The nucleotide sequence of the pntA-pntB is shown in SEQ ID No.44, the nucleotide sequence of the nadk is shown in SEQ ID No.45; and the nucleotide sequence of the ppnk is shown in SEQ ID No.
46.
2. A strain for producing indigo, characterized in that: Obtained by the construction method described in claim 1.
3. A method for producing indigo using the strain according to claim 2, characterized in that: The steps include: (1) Preparation of seed solution; (2) Shake flask fermentation; The fermentation medium used in the fermentation in step (2) contains a carbon source; When the carbon source is sodium gluconate, the concentration of sodium gluconate is 36 g / L; When the carbon sources are glucose and sodium gluconate, the concentration of the glucose is 15 g / L, and the concentration of the sodium gluconate is 18 g / L.
4. The method according to claim 3, characterized in that The fermentation temperature in step (2) is 36-38°C.
5. The method according to claim 3, characterized in that: The pH of the fermentation in step (2) is 7-10.
6. The method according to claim 3, characterized in that The fermentation time in step (2) is 36 to 48 hours.
